Coherus Biosciences Stock Forecast

Sell candidate since Jul 10, 2026 Loss -4.55%

The Coherus BioSciences stock price fell by -4.55% on the last day (Monday, 13th Jul 2026) from $1.54 to $1.47. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 3.08% from a day low at $1.46 to a day high of $1.51. The price has fallen in 6 of the last 10 days and is down by -2% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -376 thousand shares and in total, 550 thousand shares were bought and sold for approximately $808.87 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -21.40% during the next 3 months and, with a 90% probability hold a price between $0.95 and $1.29 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

CHRS Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 8.09%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Coherus BioSciences stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $1.57 and $1.50. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Coherus BioSciences stock

Coherus BioSciences finds support from accumulated volume at $1.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0450 between high and low, or 3.08%. For the last week the stock has had daily average volatility of 6.55%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CHRS) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Coherus BioSciences to open at $1.48, and during the day (based on 14 day Average True Range), to move between $1.42 and $1.52, which gives a possible trading interval of +/-$0.0976 (+/-6.87%) up or down from last closing price. If Coherus BioSciences takes out the full calculated possible swing range there will be an estimated 6.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.48 (0.68%) than the support at $1.45 (1.36%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Coherus BioSciences stock A Buy?

Coherus BioSciences holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.195 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $1.48 ( 0.567%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk